Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15678684 | 0.92 | ALOX5 (0.41) | ALOX5ALKMEN1CYP2C19KMT2A | |
| SCHEMBL15306332 | 0.90 | ALOX5 (0.40) | ALOX5ALKMEN1CYP2C19KMT2A | |
| SCHEMBL16883050 | 0.88 | ALOX5 (0.39) | ALOX5ALKMEN1CYP2C19KMT2A | |
| SCHEMBL21141341 | 0.88 | ALOX5 (0.39) | ALOX5ALKMEN1CYP2C19KMT2A | |
| SCHEMBL21168540 | 0.88 | ALOX5 (0.39) | ALOX5ALKMEN1CYP2C19KMT2A | |
| SCHEMBL25145435 | 0.88 | ALOX5 (0.39) | ALOX5ALKMEN1CYP2C19KMT2A | |
| SCHEMBL15178620 | 0.88 | ALOX5 (0.39) | ALOX5ALKMEN1CYP2C19KMT2A | |
| SCHEMBL16282243 | 0.88 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL19588620 | 0.88 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL18563242 | 0.87 | ALK (0.33) | ALKMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10361373-B2 | Condensed-cyclic compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-07-23 | — | — | US | disclosed |
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-02 | — | — | US | disclosed |
| EP-3135673-A2 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | Samsung Display Co., Ltd. (KR) | 2017-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170062720-A1 | CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LRRK2, SLC18A1, CCNT1 | ALOX5 4024/4885ALK 3067/4885MEN1 2312/4885 |
| US-10361373-B2 | Condensed-cyclic compound and organic light emitting device comprising the same | LRRK2, SLC18A1, CCNT1 | ALOX5 4024/4885ALK 3067/4885MEN1 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.